PT327 Rick Doblin, Ph.D. Confronting Abuse in Clinical Trials and the Future of Psychedelic Medicine

Published: June 14, 2022, 1:44 p.m.

b'

In this episode, David interviews Founder and Executive Director of MAPS, Rick Doblin, Ph.D. He discusses the abuse allegations unearthed in the recent \\u201cCover Story\\u201d podcast series, real-world evidence, and MAPS\' future goals.\\xa0

www.psychedelicstoday.com

'